Cibus
CBUS | NASDAQ
$1.20
+$0.07 (+6.19%)
At close: Nov 16, 2026, 4:00 PM ET
$1.20
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
+6.19%
(1D)No price chart data available for 1D timeframe.
Rating
49.8
+1.0 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #283/1021 (Top 28%)
Key Statistics
Market Data
Market Cap $91.71M
1D Range
1.07 1.21
52W Range
1.07 4.05
Valuation (TTM)
PE -0.80
PB -16.18
EV/EBITDA -2.07
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $11.50
Cash Flow
FCF Yield -47.7%
SBC Adj. FCF Yield -54.7%
SBC Impact -14.6%
Margins
Gross Margin 48.0%
Operating Margin -1125.5%
FCF Margin -966.0%
Growth (CAGR)
Revenue 3Y | 5Y 81.7% |
-34.6%
Dil EPS 3Y | 5Y 115.0% |
44.3%
FCF 3Y | 5Y 17.6% |
-13.8%
Returns
ROA -32.0%
ROE -581.5%
ROIC -17.5%
Financial Health
Net Cash
$10.13M
Current Ratio 0.95
Interest Coverage -2.60
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals...
Sector Healthcare
Industry Biotechnology
Employees 118
IPO Date Jul 20, 2017
Website www.cibus.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 12, 2026
EPS
-$0.29
Miss -42.63%
YoY:
+34.09% REV
$800K
Miss -38.46%
YoY:
+30.08%Next Earnings
Mar 16, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
2
Consensus
Hold
Price Target
$11.50
Upside
+858.33%
Buy (1)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove CBUS